Product NDC: | 10157-9539 |
Proprietary Name: | Blistex |
Non Proprietary Name: | Lanolin, Octinoxate, and Oxybenzone |
Active Ingredient(s): | 13; 7.5; 2.5 g/100g; g/100g; g/100g & nbsp; Lanolin, Octinoxate, and Oxybenzone |
Administration Route(s): | TOPICAL |
Dosage Form(s): | PASTE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10157-9539 |
Labeler Name: | Blistex Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20110701 |
Package NDC: | 10157-9539-1 |
Package Description: | 1 JAR in 1 BLISTER PACK (10157-9539-1) > 7 g in 1 JAR |
NDC Code | 10157-9539-1 |
Proprietary Name | Blistex |
Package Description | 1 JAR in 1 BLISTER PACK (10157-9539-1) > 7 g in 1 JAR |
Product NDC | 10157-9539 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Lanolin, Octinoxate, and Oxybenzone |
Dosage Form Name | PASTE |
Route Name | TOPICAL |
Start Marketing Date | 20110701 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Blistex Inc. |
Substance Name | LANOLIN; OCTINOXATE; OXYBENZONE |
Strength Number | 13; 7.5; 2.5 |
Strength Unit | g/100g; g/100g; g/100g |
Pharmaceutical Classes |